At 39, she began her journey through IVF with cautious optimism. Her first egg retrieval cycle brought in what seemed like promising numbers, 16 eggs. But when none made it to the blastocyst stage, her hopes were shaken. Her doctor, ever measured and supportive, explained that the first cycle often served as a trial run. […]
Holding On to Hope: One Woman’s IVF Journey at 39 Read More »
She experienced the heartbreak of three failed euploid embryo transfers. Despite the embryos being chromosomally normal, none resulted in a successful pregnancy. After these setbacks, she decided to try something different. Her doctors transferred a polyploid embryo, one that typically has a lower chance of success. This time, however, they introduced Omnitrope into the modified
Success with a Polyploid Embryo and Omnitrope After Multiple Failed Euploid Transfers Read More »
At 34 years old, she was diagnosed with Polycystic Ovary Syndrome (PCOS), a condition that would shape her emotional and physical journey toward motherhood. With hopes high but options limited, she began fertility treatments that would test her resilience in ways she never expected. She initially underwent several cycles of Clomid and Letrozole, two commonly
They told her the odds were just 5%. Her only embryo—graded 4BC and untested—was all she had after two grueling IVF rounds. No special protocols, no endometriosis treatment—because she didn’t even know she had it yet. That diagnosis would come much later, after a laparoscopy. But despite everything, against every statistic, he held on. Today,